drugset / Trial / NCT02040636
Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis
RandomizedParallel-groupOpen-labelPrevention
Summary
Primary objective: * To determine the safety and immunogenicity of tetanus and diphtheria toxoids adsorbed combined with component pertussis and inactivated poliomyelitis vaccine grown on vero cells (TdcP-IPV) compared to tetanus and diphtheria toxoids adsorbed combined with component pertussis and inactivated poliomyelitis vaccine grown on vero cells (TdcP-IPV) and Hepatitis B vaccine administered concurrently in adolescents 11-14 years of age. Secondary objective: * To determine whether concurrent administration of TdcP-IPV and Hepatitis B vaccines at 11-14 years of age results in detectable immunologic interactions between components of the two vaccines.
Timeline
- Start
- 1999-01
- Primary completion
- 2000-05
- Completion
- 2000-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hepatitis B vaccine | Vaccine | 0.5 ml | Intramuscular |
| Subject | Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV | Vaccine | 0.5 ml | Intramuscular |